Text Size

Heart Rate Variability Change After Liver Transplantation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2008 by National Taiwan University Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00778687
First received: October 22, 2008
Last updated: NA
Last verified: October 2008
History: No changes posted
  Purpose

Cirrhotic cardiomyopathy describes a hyperdynamic state with the presentation of high cardiac output and low systemic vascular resistance. And the latent heart failure becomes obvious under physiologic and pharmacologic stress. The goal of our study is to assess the effects of liver transplantation on the heart rate variability in patients with end stage liver disease.


Condition
Liver Transplantation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Effects of Liver Transplantation on the Heart Rate Variability in Patients With End-Stage Liver Disease

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 40
Study Start Date: October 2008
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with end stage liver disease undergoing liver transplantation

Criteria

Inclusion Criteria:

  • Age:18-70y/o receiving liver transplantation

Exclusion Criteria:

  • History of cardiovascular disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00778687

Contacts
Contact: Kuang Cheng Chan, M.D. 886-2-23123456 ext 62158 jkjchan@gmail.com

Locations
Taiwan
National Taiwan University Hospital Active, not recruiting
Taipei, Taiwan
Sponsors and Collaborators
National Taiwan University Hospital
  More Information

No publications provided

Responsible Party: Kuang Cheng Chan, National Taiwan university Hospital
ClinicalTrials.gov Identifier: NCT00778687     History of Changes
Other Study ID Numbers: 200809046R
Study First Received: October 22, 2008
Last Updated: October 22, 2008
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
End Stage Liver Disease
Liver Failure
Hepatic Insufficiency
Liver Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on June 18, 2013